ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,880Medicare Part D Prescriptions Filled, Including Refills

Rank: 105 out of 2680

$881K Total Retail Price of All Prescriptions

Rank: 94 out of 2680

580 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 11,143 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
DONEPEZIL HCL 463 455 1 28
WARFARIN SODIUM 407 377 2 12
METOPROLOL TARTRATE 331 326 3 8
LEVOTHYROXINE SODIUM 294 281 4 4
PRAVASTATIN SODIUM 275 260 5 16
SERTRALINE HCL 270 257 6 23
FUROSEMIDE 258 257 7 7
NAMENDA 232 229 8 43
AMLODIPINE BESYLATE 231 211 9 3
OMEPRAZOLE 228 213 10 2
LISINOPRIL 226 215 11 5
POTASSIUM CHLORIDE 222 220 12 29
MIRTAZAPINE 180 177 13 48
CLOPIDOGREL 173 150 14 30
TORSEMIDE 170 168 15 169
OLANZAPINE 164 164 16 128
ESCITALOPRAM OXALATE 151 148 17 82
METOPROLOL SUCCINATE 144 142 18 11
TAMIFLU 143 141 19 136
SIMVASTATIN 138 132 20 1
LIOTHYRONINE SODIUM 137 120 21 273
GABAPENTIN 136 126 22 21
FAMOTIDINE 124 119 23 65
ARICEPT 123 123 24 380
CITALOPRAM HBR 119 119 25 22
DOXYCYCLINE HYCLATE 116 112 26 237
JANUVIA 115 115 27 34
TAMSULOSIN HCL 113 113 28 25
METFORMIN HCL 112 106 29 6
PLAVIX 103 92 30 41
HYDROCODONE-ACETAMINOPHEN 102 83 S3 31 13
ATORVASTATIN CALCIUM 102 85 31 10
DIOVAN 99 89 33 26
VITAMIN D2 95 92 34 176
ATENOLOL 89 84 35 14
PAROXETINE HCL 83 76 36 62
RISPERIDONE 80 79 37 67
LOSARTAN POTASSIUM 80 80 37 18
GLIMEPIRIDE 79 76 39 51
CRESTOR 72 64 40 15
ISOSORBIDE MONONITRATE ER 71 65 41 57
XARELTO 69 67 42 499
CARBIDOPA-LEVODOPA 65 65 43 88
CLOTRIMAZOLE-BETAMETHASONE 65 65 43 109
DIGOXIN 64 64 45 59
HYDRALAZINE HCL 64 57 45 99
METHYLPHENIDATE HCL 61 53 47 514
BUPROPION XL 61 61 47 233
FLUTICASONE PROPIONATE 61 57 47 38
NEXIUM 59 59 50 19
VESICARE 58 56 51 214
TRAMADOL HCL 57 47 52 33
RAMIPRIL 55 54 53 49
LEXAPRO 53 51 54 218
AMLODIPINE BESYLATE-BENAZEPRIL 52 50 55 58
LEVETIRACETAM 52 50 55 94
CYMBALTA 52 46 55 56
BACLOFEN 51 40 58 123
MORPHINE SULFATE ER 51 46 S2 58 209
CARVEDILOL 50 47 60 27
ALLOPURINOL 50 50 60 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.